Hospira is recalling one lot of its bacteriostatic water, used to dilute or dissolve medications for injection, due to contamination concerns.
The affected product is Hospira's bacteriostatic water USP, 30 milliliter, multi-dose vial, lot W20308.
The recalled bacteriostatic water poses an increased risk for invasive bacterial infection, including bacterial meningitis and sepsis, Hospira said in a statement. It also increases the risks of limited adverse events, including fever, chills and and cutaneous abscess.
To date, the company has not received any adverse reaction reports.
The recalled bacteriostatic water was distributed to hospitals and retailers in the U.S. and Puerto Rico between March 2018 and April 2018, according to the statement.
Hospira advised its customers with an existing supply to stop use and distribution immediately.